MeSH Review:
Myasthenia Gravis
- Cellular immunity in myasthenia gravis. Response to purified acetylcholine receptor and autologous thymocytes. Richman, D.P., Patrick, J., Arnason, B.G. N. Engl. J. Med. (1976)
- Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. Scherrer, U., Vissing, S.F., Morgan, B.J., Rollins, J.A., Tindall, R.S., Ring, S., Hanson, P., Mohanty, P.K., Victor, R.G. N. Engl. J. Med. (1990)
- Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. Tindall, R.S., Rollins, J.A., Phillips, J.T., Greenlee, R.G., Wells, L., Belendiuk, G. N. Engl. J. Med. (1987)
- Sharing of antigenic determinants between the nicotinic acetylcholine receptor and proteins in Escherichia coli, Proteus vulgaris, and Klebsiella pneumoniae. Possible role in the pathogenesis of myasthenia gravis. Stefansson, K., Dieperink, M.E., Richman, D.P., Gomez, C.M., Marton, L.S. N. Engl. J. Med. (1985)
- Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Friedman, A., Kaufer, D., Shemer, J., Hendler, I., Soreq, H., Tur-Kaspa, I. Nat. Med. (1996)
- Adenosine A2 receptor-mediated excitatory actions on the nervous system. Sebastião, A.M., Ribeiro, J.A. Prog. Neurobiol. (1996)
- Protein kinase C inhibits the transplasma membrane influx of Ca2+ triggered by 4-aminopyridine in Jurkat T lymphocytes. Barbar, E., Rola-Pleszczynski, M., Payet, M.D., Dupuis, G. Biochim. Biophys. Acta (2003)
- Immunology of acetylcholine receptors in relation to myasthenia gravis. Vincent, A. Physiol. Rev. (1980)
- Myasthenia gravis unmasked by cocaine abuse. Berciano, J., Oterino, A., Rebollo, M., Pascual, J. N. Engl. J. Med. (1991)
- Positive response to edrophonium in patients with neurotoxic envenoming by cobras (Naja naja philippinensis). A placebo-controlled study. Watt, G., Theakston, R.D., Hayes, C.G., Yambao, M.L., Sangalang, R., Ranoa, C.P., Alquizalas, E., Warrell, D.A. N. Engl. J. Med. (1986)
- Thymosin alpha 1 in myasthenia gravis. Dalakas, M.C., Engel, W.K., McClure, J.E., Goldstein, A.L. N. Engl. J. Med. (1980)
- Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis. Dau, P.C., Lindstrom, J.M., Cassel, C.K., Denys, E.H., Shev, E.E., Spitler, L.E. N. Engl. J. Med. (1977)
- Cyclosporine for myasthenia gravis. Elkharrat, D., Goulon, M., Gajdos, P. N. Engl. J. Med. (1987)
- Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Hoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A., Vincent, A. Nat. Med. (2001)
- Blockade of acetylcholine receptors: a model of myasthenia gravis. Satyamurti, S., Drachman, D.B., Slone, F. Science (1975)
- Myasthenia gravis: passive transfer from man to mouse. Toyka, K.V., Brachman, D.B., Pestronk, A., Kao, I. Science (1975)
- Bromide intoxication secondary to pyridostigmine bromide therapy. Rothenberg, D.M., Berns, A.S., Barkin, R., Glantz, R.H. JAMA (1990)
- Maternal-fetal transmission of myasthenia gravis with acetylcholine-receptor antibody. Melber, D. N. Engl. J. Med. (1988)
- Regulation of acetylcholine receptor gene expression in human myasthenia gravis muscles. Evidences for a compensatory mechanism triggered by receptor loss. Guyon, T., Wakkach, A., Poea, S., Mouly, V., Klingel-Schmitt, I., Levasseur, P., Beeson, D., Asher, O., Tzartos, S., Berrih-Aknin, S. J. Clin. Invest. (1998)
- Humoral immunity in myasthenia gravis: relationship to disease severity and steroid treatment. Bradley, R.J., Dwyer, D., Morley, B.J., Robinson, G., Kemp, G.E., Oh, S.J. Lancet (1978)
- Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis. Drachman, D.B., Adams, R.N., Josifek, L.F., Self, S.G. N. Engl. J. Med. (1982)
- Effect of myasthenic immunoglobulin on acetylcholine receptors of intact mammalian neuromuscular junctions. Stanley, E.F., Drachman, D.B. Science (1978)
- Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene. Melms, A., Chrestel, S., Schalke, B.C., Wekerle, H., Mauron, A., Ballivet, M., Barkas, T. J. Clin. Invest. (1989)
- Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis. Tolosa, E., Li, W., Yasuda, Y., Wienhold, W., Denzin, L.K., Lautwein, A., Driessen, C., Schnorrer, P., Weber, E., Stevanovic, S., Kurek, R., Melms, A., Bromme, D. J. Clin. Invest. (2003)
- T helper cell recognition of muscle acetylcholine receptor in myasthenia gravis. Epitopes on the gamma and delta subunits. Manfredi, A.A., Protti, M.P., Dalton, M.W., Howard, J.F., Conti-Tronconi, B.M. J. Clin. Invest. (1993)
- Organ-specific autoantigens induce transforming growth factor-beta mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Link, J., Fredrikson, S., Söderström, M., Olsson, T., Höjeberg, B., Ljungdahl, A., Link, H. Ann. Neurol. (1994)
- IL-1 receptor antagonist-mediated therapeutic effect in murine myasthenia gravis is associated with suppressed serum proinflammatory cytokines, C3, and anti-acetylcholine receptor IgG1. Yang, H., Tüzün, E., Alagappan, D., Yu, X., Scott, B.G., Ischenko, A., Christadoss, P. J. Immunol. (2005)
- Mice with IFN-gamma receptor deficiency are less susceptible to experimental autoimmune myasthenia gravis. Zhang, G.X., Xiao, B.G., Bai, X.F., van der Meide, P.H., Orn, A., Link, H. J. Immunol. (1999)
- Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis. Feferman, T., Maiti, P.K., Berrih-Aknin, S., Bismuth, J., Bidault, J., Fuchs, S., Souroujon, M.C. J. Immunol. (2005)
- HLA-DPB1 allele associates with early-onset myasthenia gravis in Japan. Horiki, T., Moriuchi, J., Inoko, H., Morita, K., Tsuji, K., Shinohara, Y., Ichikawa, Y., Arimori, S. Neurology (1993)
- Autoimmune response to acetylcholine receptors in myasthenia gravis and its animal model. Lindstrom, J. Adv. Immunol. (1979)
- Thymopoietin and myasthenia gravis: neostigmine-responsive neuromuscular block produced in mice by a synthetic peptide fragment of thymopoietin. Goldstein, G., Schlesinger, D.H. Lancet (1975)
- Immunosuppression of experimental autoimmune myasthenia gravis by azathioprine. II. Evaluation of immunological mechanism. Tarrab-Hazdai, R., Abramsky, O., Fuchs, S. J. Immunol. (1977)
- Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice. Spuler, S., Sarropoulos, A., Marx, A., Hohlfeld, R., Wekerle, H. Am. J. Pathol. (1996)